Literature DB >> 15723231

Impaired perception of self-motion (heading) in abstinent ecstasy and marijuana users.

M Rizzo1, C T J Lamers, C G Sauer, J G Ramaekers, A Bechara, G J Andersen.   

Abstract

RATIONALE: Illicit drug use can increase driver crash risk due to loss of control over vehicle trajectory. This study asks, does recreational use of +/-3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) and tetrahydrocannabinol (THC; marijuana) impair cognitive processes that help direct our safe movement through the world?
OBJECTIVE: This study assesses the residual effects of combined MDMA/THC use, and of THC use alone, upon perceived trajectory of travel.
METHODS: Perception of self-motion, or heading, from optical flow patterns was assessed using stimuli comprising random dot ground planes presented at three different densities and eight heading angles (1, 2, 4 and 8 degrees to the left or right). On each trial, subjects reported if direction of travel was to the left or the right.
RESULTS: Results showed impairments in both drug groups, with the MDMA/THC group performing the worst.
CONCLUSIONS: The finding that these psychoactive agents adversely affect heading perception, even in recently abstinent users, raises potential concerns about MDMA use and driving ability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723231     DOI: 10.1007/s00213-004-2100-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  55 in total

1.  Cognitive performance and serotonergic function in users of ecstasy.

Authors:  R J Verkes; H J Gijsman; M S Pieters; R C Schoemaker; S de Visser; M Kuijpers; E J Pennings; D de Bruin; G Van de Wijngaart; J M Van Gerven; A F Cohen
Journal:  Psychopharmacology (Berl)       Date:  2001-01-01       Impact factor: 4.530

2.  Quantification of sleepiness: a new approach.

Authors:  E Hoddes; V Zarcone; H Smythe; R Phillips; W C Dement
Journal:  Psychophysiology       Date:  1973-07       Impact factor: 4.016

3.  Integration of direction signals of image motion in the superior temporal sulcus of the macaque monkey.

Authors:  H Saito; M Yukie; K Tanaka; K Hikosaka; Y Fukada; E Iwai
Journal:  J Neurosci       Date:  1986-01       Impact factor: 6.167

Review 4.  The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.

Authors:  S R White; T Obradovic; K M Imel; M J Wheaton
Journal:  Prog Neurobiol       Date:  1996-08       Impact factor: 11.685

Review 5.  (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.

Authors:  U D McCann; V Eligulashvili; G A Ricaurte
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

6.  Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

Authors:  M J Morgan
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

7.  Central and peripheral vision loss associated with nefazodone usage.

Authors:  Chi Luu; Patricia Kiely; David Crewther; Lionel Kowal; Sheila Crewther
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

8.  Vision and driving in the elderly.

Authors:  C Owsley
Journal:  Optom Vis Sci       Date:  1994-12       Impact factor: 1.973

Review 9.  Disorders of motion and depth.

Authors:  Mark Nawrot
Journal:  Neurol Clin       Date:  2003-08       Impact factor: 3.806

10.  Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.

Authors:  P Marquet; P A Delpla; S Kerguelen; J Bremond; F Facy; M Garnier; B Guery; M Lhermitte; D Mathé; A L Pelissier; C Renaudeau; P Vest; J P Seguela
Journal:  J Forensic Sci       Date:  1998-07       Impact factor: 1.832

View more
  9 in total

1.  Risky car following in abstinent users of MDMA.

Authors:  Elizabeth Dastrup; Monica N Lees; Antoine Bechara; Jeffrey D Dawson; Matthew Rizzo
Journal:  Accid Anal Prev       Date:  2010-05

2.  The impact of cannabis on driving.

Authors:  Michel Bédard; Sacha Dubois; Bruce Weaver
Journal:  Can J Public Health       Date:  2007 Jan-Feb

Review 3.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

4.  Contrast sensitivity and motion discrimination in cannabis users.

Authors:  Elena Mikulskaya; Frances Heritage Martin
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

5.  Alterations to global but not local motion processing in long-term ecstasy (MDMA) users.

Authors:  Claire White; John Brown; Mark Edwards
Journal:  Psychopharmacology (Berl)       Date:  2014-01-19       Impact factor: 4.530

Review 6.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

7.  Measuring listening effort: driving simulator versus simple dual-task paradigm.

Authors:  Yu-Hsiang Wu; Nazan Aksan; Matthew Rizzo; Elizabeth Stangl; Xuyang Zhang; Ruth Bentler
Journal:  Ear Hear       Date:  2014 Nov-Dec       Impact factor: 3.570

Review 8.  Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users.

Authors:  A C Parrott
Journal:  Neuropsychobiology       Date:  2009-11-05       Impact factor: 2.328

9.  Effects of cannabis on visual function and self-perceived visual quality.

Authors:  Sonia Ortiz-Peregrina; Carolina Ortiz; Miriam Casares-López; José R Jiménez; Rosario G Anera
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.